SlideShare ist ein Scribd-Unternehmen logo
1 von 14
Downloaden Sie, um offline zu lesen
Tuberculosis :
Prevention,Diagnosis &
treatment
PRESENTED BY :- RAJNISH KUMAR
(RESEARCH SCHOLOR, SOCIAL WORK,
(MGKVP, VARANASI)
Introduction
 TB is an airborne disease caused by the bacterium Mycobacterium tuberculosis (M.
tuberculosis). M. tuberculosis and seven very closely related mycobacterial species (M. bovis,
M. africanum, M. microti, M. caprae, M. pinnipedii, M. canetti and M. mungi) together
comprise what is known as the M. tuberculosis complex. Most, but not all, of these species
have been found to cause disease in humans. In the United States, the majority of TB cases
are caused by M. tuberculosis. M. tuberculosis organisms are also called tubercle bacilli.
 Each year, we commemorate World Tuberculosis (TB) Day on March 24 to raise public
awareness about the devastating health, social and economic consequences of TB, and to
step up efforts to end the global TB epidemic. The date marks the day in 1882 when Dr
Robert Koch announced that he had discovered the bacterium that causes TB, which
opened the way towards diagnosing and curing this disease.
Continued….
India is the highest TB burden country in the world having an estimated incidence of 26.9 lakh
cases in 2019 (WHO). To address this, the ability to achieve complete surveillance coverage is the
prerequisite
The theme of World TB Day 2020 - ‘It’s time’ – puts the accent on the urgency to act on the
commitments made by global leaders to:
 scale up access to prevention and treatment;
 build accountability;
 ensure sufficient and sustainable financing including for research;
 promote an end to stigma and discrimination, and
 promote an equitable, rights-based and people-centered TB response.
Transmission of TB
 M. tuberculosis is carried in airborne particles, called droplet nuclei, of 1– 5
microns in diameter. Infectious droplet nuclei are generated when persons who
have pulmonary or laryngeal TB disease cough, sneeze, shout, or sing.
Depending on the environment, these tiny particles can remain suspended in the
air for several hours. M. tuberculosis is transmitted through the air, not by surface
contact. Transmission occurs when a person inhales droplet nuclei containing M.
tuberculosis, and the droplet nuclei traverse the mouth or nasal passages, upper
respiratory tract, and bronchi to reach the alveoli of the lungs
Factors that Determine the Probability of
Transmission of M. tuberculosis
Factor Description
Susceptibility Susceptibility (immune status) of the exposed
individual
Infectiousness Infectiousness of the person with TB disease
is directly related to the number of tubercle
bacilli that he or she expels into the air.
Persons who expel many tubercle bacilli are
more infectious than patients who expel few
or no bacilli
Environment Environmental factors that affect the
concentration of M. tuberculosis organisms
Exposure Proximity, frequency, and duration of
exposure
Diagnosis
 Microscopy of specially stained sputum is the main test for diagnosing TB (1‐2 days)
 TB bacilli seen in the sputum sample using a microscope (smear positive or AFB +)
 Detects only ½of all TB and 1/3rd of HIV related TB
 PLHIV higher proportion of –sputum negative pulmonary TB –extrapulmonary TB
 X ‐ray also has a role for diagnosing TB if smear negative.
 Role of culture: (takes 3 ‐4 wks.)
 EPTB may require tissue samples/culture
 Diagnostic process will differ depending on the setting (rural/urban/laboratory capacity/ava
ilability of X-ray/culture)
How is TB diagnosed?
 Bacteriological confirmation
–Sputum smear microscopy
–Culture
 Non-bacteriological
–Symptom screen
–TST or Mantoux or PPD
–Chest X-ray
–Diagnostic algorithm
Tuberculosis Case definition
 TB case -A patient in whom tuberculosis has been confirmed by bacteriology
ordiagnosed by a clinician.
 Smear positive pulmonary TB case -A patient with one or more positive sputum
smear examinations (direct smear microscopy) AFB+.
 Smear negative pulmonary TB case –A patient with two sputum smear
examinations negative for AFB; X ray suggests TB, unresponsive to a course of broad-
spectrum antibiotics (except in a patient with strong clinical evidence of HIV infection); and
a decision by a clinician to treat with anti tuberculosis chemotherapy; or positive culture but
negative AFB sputum examinations.
 Extrapulmonary TB case -one culture-positive specimen, or histological or strong
clinical evidence. Followed by decision by a clinician to treat with a full course of anti-
tuberculosis chemotherapy
Treatment
TB is treatable and curable, even in people living with HIV.
First line TB drugs:-
 Rifampicin(R), Isoniazid(H) ,Ethambutol(E) , Pyrazinamide(Z)
Gaps in first-line treatment:-
 High pill burden
 Long duration of treatment
 Side effects
 Drug stock outs
 Interactions with ARVs
 Little to no pediatric data
Performance and Achievement in
2019 (Drug Sensitive TB)
 For the first time in the history of TB program implementation, total TB case
notification during 2019 has crossed 24 lakhs which include 6.79 lakh cases notified
from the private sector and 17.3 lakh notified from the public sectors. Among the
above, 16.8 (94%) and 5.9 (95%) patients were initiated on treatment in public and
private sector respectively.
 used 58,330 4 FDC and 91,159 3 FDC blisters of free drugs for private sector TB
patients treatment. The ‘free provision of diagnostic and drugs’ is expected to
reduce the out of pocket expenditure among TB patient and their families.
So how do we prevent TB infection and disease?
 Primary prevention aims to block infection.
 Secondary prevention aims to block progression of an infection to active disease.
*How could you prevent TB infection?
 1.Involve patients & community in advocacy campaigns
 2.Infection control plan
 3.Safe sputum collection
 4.Cough etiquette and cough hygiene
 5.Triage TB suspects to fast tract or separation
 6.Rapid TB diagnosis and treatment
 7.Improve room air ventilation
 8.Protect health care workers
 9.Capacity building
 10.Monitor infection control practices.
How can we prevent TB disease?
 Bacillus Calmette-Guerin (or BCG) vaccine - The Bacille Calmette- Guérin
(BCG) is the ONLY successful TB vaccine Was introduced in 1921. BCG is the world’s
most widely administered vaccine.
 Isoniazid preventive therapy (IPT) – Isoniazid treatment for 6 months given to
people with HIV can reduce by 40-60% .
 Antiretroviral therapy (ART) for people with HIV - ART helps to restore
immune function. ART can greatly reduce the risk of TB in a person living with HIV. But
risk still elevated to about 2x that in a person without HIV
Summary
 To meet the ambitious goal pronounced by our Honorable Prime Minister at the Delhi End TB
Summit in March 2018 of ending the TB epidemic by 2025 from the country, five years ahead
of SDG goals for 2030, responding to which, some States/ UTs have committed to end TB even
before 2025 - Kerala (2020), Himachal Pradesh (2021), Sikkim, Lakshadweep (2022)
Chhattisgarh, Jammu & Kashmir, Madhya Pradesh, Tamil Nadu and Bihar, Jharkhand,
Puducherry and Dadra Nagar Havelli & Daman Diu (2025). The programme has now been
renamed as National Tuberculosis Elimination Programme, to invigorate the fight in alignment
with this ambition.
 The TB Sample Transport Network has been widened through support from Department of
Post’s services for specimen transportation from peripheral health facilities to TB diagnostic
laboratories. This will help expand drug susceptibility testing services. The last three years has
seen several policies and interventions augmenting the ambitious target of ending TB in India.
The coming years will see the programme build on the progress already made and intensify
efforts at expanding access and improving the quality of services to ensure optimum impact.
References
 American Thoracic Society and CDC. Diagnostic standards and classification of tuberculosis
in adults and children. Am J Respir Crit Care Med 2000; 161 (4): 1376– 1395.
http://ajrccm.atsjournals.org/cgi/reprint/161/4/1376
 Biswas, J. N. (1996-1997). Pattern of uveitis in a referral uveitis clinic in India. International
Ophthalmology , 20 (4), 223-8.
 Sharma S.K., M. A. (2004). Extrapulmonary tuberculosis. Indian Journal of Medical Research
, 120 (4), 316-353.
 Sharma, P. T. (2015). Clinical and biochemical profile of tuberculosis in patients with liver
cirrhosis. Journal of Clinical and Experimental Hepatology , 5, 8-13.
 Singh, R. G. (2004). Pattern of uveitis in a referral eye clinic in north India. Indian Journal of
Ophthalmology , 52, 121-5
 Global Tuberculosis Control 2009 :Epidemiology, Strategy, Financing. Geneva, World Health
Organization, 2009.
 https://tbcindia.gov.in/showfile.php?lid=3538

Weitere ähnliche Inhalte

Was ist angesagt?

Was ist angesagt? (20)

update on Swine flu (H1N1)
update on Swine flu (H1N1)update on Swine flu (H1N1)
update on Swine flu (H1N1)
 
Lect 5 - Respiratory viruses
Lect 5 - Respiratory virusesLect 5 - Respiratory viruses
Lect 5 - Respiratory viruses
 
EPIDEMIOLOGY OF TUBERCULOSIS
EPIDEMIOLOGY OF TUBERCULOSISEPIDEMIOLOGY OF TUBERCULOSIS
EPIDEMIOLOGY OF TUBERCULOSIS
 
Smallpox
Smallpox Smallpox
Smallpox
 
Influenza vaccines
Influenza vaccinesInfluenza vaccines
Influenza vaccines
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Emerging and re emerging infections
Emerging and re emerging infectionsEmerging and re emerging infections
Emerging and re emerging infections
 
acute respiratory tract infection
acute respiratory tract infectionacute respiratory tract infection
acute respiratory tract infection
 
Viral hepatitis
Viral hepatitisViral hepatitis
Viral hepatitis
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
HIV epidemiology and pathogenesis
HIV epidemiology and pathogenesis HIV epidemiology and pathogenesis
HIV epidemiology and pathogenesis
 
HIV AIDS
HIV AIDSHIV AIDS
HIV AIDS
 
H1 N1 influenza (swine flu)
H1 N1 influenza (swine flu)H1 N1 influenza (swine flu)
H1 N1 influenza (swine flu)
 
Epidemiology & prevention of tuberculosis
Epidemiology & prevention of tuberculosisEpidemiology & prevention of tuberculosis
Epidemiology & prevention of tuberculosis
 
-Influenza-epidemiology,prevention and control
-Influenza-epidemiology,prevention and control-Influenza-epidemiology,prevention and control
-Influenza-epidemiology,prevention and control
 
Tuberclosis
TuberclosisTuberclosis
Tuberclosis
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Tuberculosis & hiv coexistence
Tuberculosis & hiv coexistenceTuberculosis & hiv coexistence
Tuberculosis & hiv coexistence
 

Ähnlich wie Tuberculosis at glance

Recent advances in diagnosis and treatment of tuberculosis
Recent advances in diagnosis and treatment of tuberculosisRecent advances in diagnosis and treatment of tuberculosis
Recent advances in diagnosis and treatment of tuberculosisAdeyemiKayode2
 
Sam higgimbottom institute of agriculture technology and sciences
Sam higgimbottom institute of agriculture technology and sciencesSam higgimbottom institute of agriculture technology and sciences
Sam higgimbottom institute of agriculture technology and sciencesAbhishek Sunny
 
Prevention of mycobateria tuberculosis in healthcare settings
Prevention of mycobateria tuberculosis in healthcare settingsPrevention of mycobateria tuberculosis in healthcare settings
Prevention of mycobateria tuberculosis in healthcare settingsMoustapha Ramadan
 
Bio303 Lecture 2 Two Old Enemies, TB and Leprosy
Bio303 Lecture 2 Two Old Enemies, TB and LeprosyBio303 Lecture 2 Two Old Enemies, TB and Leprosy
Bio303 Lecture 2 Two Old Enemies, TB and LeprosyMark Pallen
 
Miss farida's presentation
Miss farida's presentationMiss farida's presentation
Miss farida's presentationMubashar Alam
 
Tuberculosis ( Tb ) Is A Bacterial Infection Disease...
Tuberculosis ( Tb ) Is A Bacterial Infection Disease...Tuberculosis ( Tb ) Is A Bacterial Infection Disease...
Tuberculosis ( Tb ) Is A Bacterial Infection Disease...Erika Morris
 
Pulmonary tuberculosis
Pulmonary tuberculosisPulmonary tuberculosis
Pulmonary tuberculosisMedicinaIngles
 
GUIDELINES FOR THE MANAGEMENT OF TUBERCULOSIS IN CHILDREN
GUIDELINES FOR THE MANAGEMENT OF TUBERCULOSIS IN CHILDREN GUIDELINES FOR THE MANAGEMENT OF TUBERCULOSIS IN CHILDREN
GUIDELINES FOR THE MANAGEMENT OF TUBERCULOSIS IN CHILDREN Surya Amal
 
DIAGNOSIS AND MANAGEMENT OF TUBERCULOSIS IN INDIA - CURRENT SCENARIO
DIAGNOSIS AND MANAGEMENT OF TUBERCULOSIS IN INDIA - CURRENT SCENARIODIAGNOSIS AND MANAGEMENT OF TUBERCULOSIS IN INDIA - CURRENT SCENARIO
DIAGNOSIS AND MANAGEMENT OF TUBERCULOSIS IN INDIA - CURRENT SCENARIOKatySam
 
Tuberculosis infection control program - CDC guidelines
Tuberculosis infection control program - CDC guidelinesTuberculosis infection control program - CDC guidelines
Tuberculosis infection control program - CDC guidelinesAman Tong
 
epidemiologypreventionoftuberculosis-150912091236-lva1-app6892.pptx
epidemiologypreventionoftuberculosis-150912091236-lva1-app6892.pptxepidemiologypreventionoftuberculosis-150912091236-lva1-app6892.pptx
epidemiologypreventionoftuberculosis-150912091236-lva1-app6892.pptxDebdattaMandal5
 

Ähnlich wie Tuberculosis at glance (20)

Icic.pptx
Icic.pptxIcic.pptx
Icic.pptx
 
Recent advances in diagnosis and treatment of tuberculosis
Recent advances in diagnosis and treatment of tuberculosisRecent advances in diagnosis and treatment of tuberculosis
Recent advances in diagnosis and treatment of tuberculosis
 
Sam higgimbottom institute of agriculture technology and sciences
Sam higgimbottom institute of agriculture technology and sciencesSam higgimbottom institute of agriculture technology and sciences
Sam higgimbottom institute of agriculture technology and sciences
 
Epidemiology
EpidemiologyEpidemiology
Epidemiology
 
Communicable diseases
Communicable diseasesCommunicable diseases
Communicable diseases
 
TB(Tuberculosis)
TB(Tuberculosis)TB(Tuberculosis)
TB(Tuberculosis)
 
Prevention of mycobateria tuberculosis in healthcare settings
Prevention of mycobateria tuberculosis in healthcare settingsPrevention of mycobateria tuberculosis in healthcare settings
Prevention of mycobateria tuberculosis in healthcare settings
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Bio303 Lecture 2 Two Old Enemies, TB and Leprosy
Bio303 Lecture 2 Two Old Enemies, TB and LeprosyBio303 Lecture 2 Two Old Enemies, TB and Leprosy
Bio303 Lecture 2 Two Old Enemies, TB and Leprosy
 
Introduction
IntroductionIntroduction
Introduction
 
Miss farida's presentation
Miss farida's presentationMiss farida's presentation
Miss farida's presentation
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Tuberculosis ( Tb ) Is A Bacterial Infection Disease...
Tuberculosis ( Tb ) Is A Bacterial Infection Disease...Tuberculosis ( Tb ) Is A Bacterial Infection Disease...
Tuberculosis ( Tb ) Is A Bacterial Infection Disease...
 
Pulmonary tuberculosis
Pulmonary tuberculosisPulmonary tuberculosis
Pulmonary tuberculosis
 
HIV/AIDS & TB
HIV/AIDS & TBHIV/AIDS & TB
HIV/AIDS & TB
 
GUIDELINES FOR THE MANAGEMENT OF TUBERCULOSIS IN CHILDREN
GUIDELINES FOR THE MANAGEMENT OF TUBERCULOSIS IN CHILDREN GUIDELINES FOR THE MANAGEMENT OF TUBERCULOSIS IN CHILDREN
GUIDELINES FOR THE MANAGEMENT OF TUBERCULOSIS IN CHILDREN
 
DIAGNOSIS AND MANAGEMENT OF TUBERCULOSIS IN INDIA - CURRENT SCENARIO
DIAGNOSIS AND MANAGEMENT OF TUBERCULOSIS IN INDIA - CURRENT SCENARIODIAGNOSIS AND MANAGEMENT OF TUBERCULOSIS IN INDIA - CURRENT SCENARIO
DIAGNOSIS AND MANAGEMENT OF TUBERCULOSIS IN INDIA - CURRENT SCENARIO
 
Tuberculosis infection control program - CDC guidelines
Tuberculosis infection control program - CDC guidelinesTuberculosis infection control program - CDC guidelines
Tuberculosis infection control program - CDC guidelines
 
epidemiologypreventionoftuberculosis-150912091236-lva1-app6892.pptx
epidemiologypreventionoftuberculosis-150912091236-lva1-app6892.pptxepidemiologypreventionoftuberculosis-150912091236-lva1-app6892.pptx
epidemiologypreventionoftuberculosis-150912091236-lva1-app6892.pptx
 
Tuberculosis in english tb
Tuberculosis in english tbTuberculosis in english tb
Tuberculosis in english tb
 

Mehr von Rehab India Foundation (12)

History of medical social work in India
History of medical social work in IndiaHistory of medical social work in India
History of medical social work in India
 
History of medical social work in abroad
History of medical social work in abroadHistory of medical social work in abroad
History of medical social work in abroad
 
Health policy in india
Health policy in indiaHealth policy in india
Health policy in india
 
Health indicators
Health indicatorsHealth indicators
Health indicators
 
Health care infrastructure in rural India
Health care infrastructure in rural IndiaHealth care infrastructure in rural India
Health care infrastructure in rural India
 
Health care in urban India
Health care in urban IndiaHealth care in urban India
Health care in urban India
 
Health in five year plan in India
Health in five year plan in India Health in five year plan in India
Health in five year plan in India
 
Health as an aspect of social development
Health as an aspect of social development Health as an aspect of social development
Health as an aspect of social development
 
Diabetes at glance
Diabetes at glanceDiabetes at glance
Diabetes at glance
 
Breast cancer
Breast cancerBreast cancer
Breast cancer
 
Bhore committee
Bhore committeeBhore committee
Bhore committee
 
Breast cancer awareness
Breast cancer awarenessBreast cancer awareness
Breast cancer awareness
 

Kürzlich hochgeladen

Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.kishan singh tomar
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...Shubhanshu Gaurav
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu Medical University
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyZurück zum Ursprung
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)kishan singh tomar
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptPradnya Wadekar
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communicationskatiequigley33
 
Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu Medical University
 
Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Peter Embi
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project reportNARMADAPETROLEUMGAS
 
Microbiology lecture presentation-1.pptx
Microbiology lecture presentation-1.pptxMicrobiology lecture presentation-1.pptx
Microbiology lecture presentation-1.pptxkitati1
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Vaikunthan Rajaratnam
 
Good Laboratory Practice (GLP) in Pharma-LikeWays.pptx
Good Laboratory Practice (GLP) in Pharma-LikeWays.pptxGood Laboratory Practice (GLP) in Pharma-LikeWays.pptx
Good Laboratory Practice (GLP) in Pharma-LikeWays.pptxLikeways
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfHongBiThi1
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondSujoy Dasgupta
 
The Importance of Mental Health: Why is Mental Health Important?
The Importance of Mental Health: Why is Mental Health Important?The Importance of Mental Health: Why is Mental Health Important?
The Importance of Mental Health: Why is Mental Health Important?Ryan Addison
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionkrishnareddy157915
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxMAsifAhmad
 
Role of Soap based and synthetic or syndets bar
Role of  Soap based and synthetic or syndets barRole of  Soap based and synthetic or syndets bar
Role of Soap based and synthetic or syndets barmohitRahangdale
 

Kürzlich hochgeladen (20)

Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
 
Cone beam CT: concepts and applications.pptx
Cone beam CT: concepts and applications.pptxCone beam CT: concepts and applications.pptx
Cone beam CT: concepts and applications.pptx
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturally
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologyppt
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communications
 
Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu
 
Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project report
 
Microbiology lecture presentation-1.pptx
Microbiology lecture presentation-1.pptxMicrobiology lecture presentation-1.pptx
Microbiology lecture presentation-1.pptx
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.
 
Good Laboratory Practice (GLP) in Pharma-LikeWays.pptx
Good Laboratory Practice (GLP) in Pharma-LikeWays.pptxGood Laboratory Practice (GLP) in Pharma-LikeWays.pptx
Good Laboratory Practice (GLP) in Pharma-LikeWays.pptx
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and Beyond
 
The Importance of Mental Health: Why is Mental Health Important?
The Importance of Mental Health: Why is Mental Health Important?The Importance of Mental Health: Why is Mental Health Important?
The Importance of Mental Health: Why is Mental Health Important?
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung function
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
 
Role of Soap based and synthetic or syndets bar
Role of  Soap based and synthetic or syndets barRole of  Soap based and synthetic or syndets bar
Role of Soap based and synthetic or syndets bar
 

Tuberculosis at glance

  • 1. Tuberculosis : Prevention,Diagnosis & treatment PRESENTED BY :- RAJNISH KUMAR (RESEARCH SCHOLOR, SOCIAL WORK, (MGKVP, VARANASI)
  • 2. Introduction  TB is an airborne disease caused by the bacterium Mycobacterium tuberculosis (M. tuberculosis). M. tuberculosis and seven very closely related mycobacterial species (M. bovis, M. africanum, M. microti, M. caprae, M. pinnipedii, M. canetti and M. mungi) together comprise what is known as the M. tuberculosis complex. Most, but not all, of these species have been found to cause disease in humans. In the United States, the majority of TB cases are caused by M. tuberculosis. M. tuberculosis organisms are also called tubercle bacilli.  Each year, we commemorate World Tuberculosis (TB) Day on March 24 to raise public awareness about the devastating health, social and economic consequences of TB, and to step up efforts to end the global TB epidemic. The date marks the day in 1882 when Dr Robert Koch announced that he had discovered the bacterium that causes TB, which opened the way towards diagnosing and curing this disease.
  • 3. Continued…. India is the highest TB burden country in the world having an estimated incidence of 26.9 lakh cases in 2019 (WHO). To address this, the ability to achieve complete surveillance coverage is the prerequisite The theme of World TB Day 2020 - ‘It’s time’ – puts the accent on the urgency to act on the commitments made by global leaders to:  scale up access to prevention and treatment;  build accountability;  ensure sufficient and sustainable financing including for research;  promote an end to stigma and discrimination, and  promote an equitable, rights-based and people-centered TB response.
  • 4. Transmission of TB  M. tuberculosis is carried in airborne particles, called droplet nuclei, of 1– 5 microns in diameter. Infectious droplet nuclei are generated when persons who have pulmonary or laryngeal TB disease cough, sneeze, shout, or sing. Depending on the environment, these tiny particles can remain suspended in the air for several hours. M. tuberculosis is transmitted through the air, not by surface contact. Transmission occurs when a person inhales droplet nuclei containing M. tuberculosis, and the droplet nuclei traverse the mouth or nasal passages, upper respiratory tract, and bronchi to reach the alveoli of the lungs
  • 5. Factors that Determine the Probability of Transmission of M. tuberculosis Factor Description Susceptibility Susceptibility (immune status) of the exposed individual Infectiousness Infectiousness of the person with TB disease is directly related to the number of tubercle bacilli that he or she expels into the air. Persons who expel many tubercle bacilli are more infectious than patients who expel few or no bacilli Environment Environmental factors that affect the concentration of M. tuberculosis organisms Exposure Proximity, frequency, and duration of exposure
  • 6. Diagnosis  Microscopy of specially stained sputum is the main test for diagnosing TB (1‐2 days)  TB bacilli seen in the sputum sample using a microscope (smear positive or AFB +)  Detects only ½of all TB and 1/3rd of HIV related TB  PLHIV higher proportion of –sputum negative pulmonary TB –extrapulmonary TB  X ‐ray also has a role for diagnosing TB if smear negative.  Role of culture: (takes 3 ‐4 wks.)  EPTB may require tissue samples/culture  Diagnostic process will differ depending on the setting (rural/urban/laboratory capacity/ava ilability of X-ray/culture)
  • 7. How is TB diagnosed?  Bacteriological confirmation –Sputum smear microscopy –Culture  Non-bacteriological –Symptom screen –TST or Mantoux or PPD –Chest X-ray –Diagnostic algorithm
  • 8. Tuberculosis Case definition  TB case -A patient in whom tuberculosis has been confirmed by bacteriology ordiagnosed by a clinician.  Smear positive pulmonary TB case -A patient with one or more positive sputum smear examinations (direct smear microscopy) AFB+.  Smear negative pulmonary TB case –A patient with two sputum smear examinations negative for AFB; X ray suggests TB, unresponsive to a course of broad- spectrum antibiotics (except in a patient with strong clinical evidence of HIV infection); and a decision by a clinician to treat with anti tuberculosis chemotherapy; or positive culture but negative AFB sputum examinations.  Extrapulmonary TB case -one culture-positive specimen, or histological or strong clinical evidence. Followed by decision by a clinician to treat with a full course of anti- tuberculosis chemotherapy
  • 9. Treatment TB is treatable and curable, even in people living with HIV. First line TB drugs:-  Rifampicin(R), Isoniazid(H) ,Ethambutol(E) , Pyrazinamide(Z) Gaps in first-line treatment:-  High pill burden  Long duration of treatment  Side effects  Drug stock outs  Interactions with ARVs  Little to no pediatric data
  • 10. Performance and Achievement in 2019 (Drug Sensitive TB)  For the first time in the history of TB program implementation, total TB case notification during 2019 has crossed 24 lakhs which include 6.79 lakh cases notified from the private sector and 17.3 lakh notified from the public sectors. Among the above, 16.8 (94%) and 5.9 (95%) patients were initiated on treatment in public and private sector respectively.  used 58,330 4 FDC and 91,159 3 FDC blisters of free drugs for private sector TB patients treatment. The ‘free provision of diagnostic and drugs’ is expected to reduce the out of pocket expenditure among TB patient and their families.
  • 11. So how do we prevent TB infection and disease?  Primary prevention aims to block infection.  Secondary prevention aims to block progression of an infection to active disease. *How could you prevent TB infection?  1.Involve patients & community in advocacy campaigns  2.Infection control plan  3.Safe sputum collection  4.Cough etiquette and cough hygiene  5.Triage TB suspects to fast tract or separation  6.Rapid TB diagnosis and treatment  7.Improve room air ventilation  8.Protect health care workers  9.Capacity building  10.Monitor infection control practices.
  • 12. How can we prevent TB disease?  Bacillus Calmette-Guerin (or BCG) vaccine - The Bacille Calmette- Guérin (BCG) is the ONLY successful TB vaccine Was introduced in 1921. BCG is the world’s most widely administered vaccine.  Isoniazid preventive therapy (IPT) – Isoniazid treatment for 6 months given to people with HIV can reduce by 40-60% .  Antiretroviral therapy (ART) for people with HIV - ART helps to restore immune function. ART can greatly reduce the risk of TB in a person living with HIV. But risk still elevated to about 2x that in a person without HIV
  • 13. Summary  To meet the ambitious goal pronounced by our Honorable Prime Minister at the Delhi End TB Summit in March 2018 of ending the TB epidemic by 2025 from the country, five years ahead of SDG goals for 2030, responding to which, some States/ UTs have committed to end TB even before 2025 - Kerala (2020), Himachal Pradesh (2021), Sikkim, Lakshadweep (2022) Chhattisgarh, Jammu & Kashmir, Madhya Pradesh, Tamil Nadu and Bihar, Jharkhand, Puducherry and Dadra Nagar Havelli & Daman Diu (2025). The programme has now been renamed as National Tuberculosis Elimination Programme, to invigorate the fight in alignment with this ambition.  The TB Sample Transport Network has been widened through support from Department of Post’s services for specimen transportation from peripheral health facilities to TB diagnostic laboratories. This will help expand drug susceptibility testing services. The last three years has seen several policies and interventions augmenting the ambitious target of ending TB in India. The coming years will see the programme build on the progress already made and intensify efforts at expanding access and improving the quality of services to ensure optimum impact.
  • 14. References  American Thoracic Society and CDC. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000; 161 (4): 1376– 1395. http://ajrccm.atsjournals.org/cgi/reprint/161/4/1376  Biswas, J. N. (1996-1997). Pattern of uveitis in a referral uveitis clinic in India. International Ophthalmology , 20 (4), 223-8.  Sharma S.K., M. A. (2004). Extrapulmonary tuberculosis. Indian Journal of Medical Research , 120 (4), 316-353.  Sharma, P. T. (2015). Clinical and biochemical profile of tuberculosis in patients with liver cirrhosis. Journal of Clinical and Experimental Hepatology , 5, 8-13.  Singh, R. G. (2004). Pattern of uveitis in a referral eye clinic in north India. Indian Journal of Ophthalmology , 52, 121-5  Global Tuberculosis Control 2009 :Epidemiology, Strategy, Financing. Geneva, World Health Organization, 2009.  https://tbcindia.gov.in/showfile.php?lid=3538